Inventor · disambiguated record
Xinliang Xu
Also filed as: XU XINLIANG
2 granted patents·2 pending applications·1 citations·filing 2021–2023
38Inventor score
Files withGNT PHARMA CO LTD4
Top patents by PatentIndex Score
4 records- 0177US11826329B2Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapyGNT PHARMA CO LTD·Filed 2021·Granted Nov 28, 2023·1 cites·19 claims
- 0270US12433861B2Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapyGNT PHARMA CO LTD·Filed 2023·Granted Oct 7, 2025·0 cites·20 claims
- 0353US2024116853A12-hydroxy-5-[2-(4-(trifluoromethylphenyl)ethylamino)]benzoic acid crystal forms and preparation method thereforGNT PHARMA CO LTD·Filed 2021·Application pending·0 cites
- 0453US2024051915A1Method for preparing 2-hydroxy-5-[2-(4-(trifluoromethylphenyl)ethylamino)]benzoic acidGNT PHARMA CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xinliang Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →